Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism.
Hepatic xenobiotic metabolism
Lipoprotein metabolism
Platelet aggregation
Sexual dimorphism
Trimethylamine-N-oxide
Journal
JHEP reports : innovation in hepatology
ISSN: 2589-5559
Titre abrégé: JHEP Rep
Pays: Netherlands
ID NLM: 101761237
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
received:
17
04
2023
revised:
25
09
2023
accepted:
27
09
2023
medline:
27
12
2023
pubmed:
27
12
2023
entrez:
27
12
2023
Statut:
epublish
Résumé
The constitutive androstane receptor (CAR) is a nuclear receptor that binds diverse xenobiotics and whose activation leads to the modulation of the expression of target genes involved in xenobiotic detoxification and energy metabolism. Although CAR hepatic activity is considered to be higher in women than in men, its sex-dependent response to an acute pharmacological activation has seldom been investigated. The hepatic transcriptome, plasma markers, and hepatic metabolome, were analysed in Although 90% of TCPOBOP-sensitive genes were modulated in a sex-independent manner, the remaining 10% showed almost exclusive female liver specificity. These female-specific More than 10% of CAR-sensitive genes are sex-specific and influence hepatic and systemic responses such as platelet aggregation. CAR activation may be an important mechanism of sexually-dimorphic drug-induced liver injury. CAR is activated by many drugs and pollutants. Its pharmacological activation had a stronger impact on hepatic gene expression and metabolism in females than in males, and had a specific impact on liver toxicity and trimethylamine metabolism. Sexual dimorphism should be considered when testing and/or prescribing xenobiotics known to activate CAR.
Sections du résumé
Background & Aims
UNASSIGNED
The constitutive androstane receptor (CAR) is a nuclear receptor that binds diverse xenobiotics and whose activation leads to the modulation of the expression of target genes involved in xenobiotic detoxification and energy metabolism. Although CAR hepatic activity is considered to be higher in women than in men, its sex-dependent response to an acute pharmacological activation has seldom been investigated.
Methods
UNASSIGNED
The hepatic transcriptome, plasma markers, and hepatic metabolome, were analysed in
Results
UNASSIGNED
Although 90% of TCPOBOP-sensitive genes were modulated in a sex-independent manner, the remaining 10% showed almost exclusive female liver specificity. These female-specific
Conclusions
UNASSIGNED
More than 10% of CAR-sensitive genes are sex-specific and influence hepatic and systemic responses such as platelet aggregation. CAR activation may be an important mechanism of sexually-dimorphic drug-induced liver injury.
Impact and implications
UNASSIGNED
CAR is activated by many drugs and pollutants. Its pharmacological activation had a stronger impact on hepatic gene expression and metabolism in females than in males, and had a specific impact on liver toxicity and trimethylamine metabolism. Sexual dimorphism should be considered when testing and/or prescribing xenobiotics known to activate CAR.
Identifiants
pubmed: 38149074
doi: 10.1016/j.jhepr.2023.100930
pii: S2589-5559(23)00261-6
pmc: PMC10749885
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100930Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest. Please refer to the accompanying ICMJE disclosure forms for further details.